v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Consolidated Statements of Operations    
PEDMARK product sales, net $ 15,108 $ 8,751
Operating expenses:    
Cost of product sales 570 373
Research and development 49 94
Selling and marketing 11,422 3,227
General and administrative 3,186 5,865
Total operating expenses 15,227 9,559
(Loss)/income from operations (119) (808)
Other income/(expense)    
Unrealized foreign exchange gain/(loss) (12) 13
Amortization expense   (13)
Unrealized loss on securities   (1)
Interest income 339 236
Interest expense (7) (592)
Total other expense 320 (357)
Net loss $ 201 $ (1,165)
Basic net loss per common share $ 0.01 $ (0.04)
Diluted net loss per common share $ 0.01 $ (0.04)
Weighted-average number of common shares outstanding basic 34,336 27,578
Weighted-average number of common shares outstanding diluted 35,548 27,578